185 filings
Page 3 of 10
8-K
zn4cj1z9l5qaehjwb
21 May 20
Regulation FD Disclosure
4:54pm
8-K
zra4mzf0v5942
6 May 20
Bio-Rad Reports First-Quarter 2020 Financial Results
4:46pm
8-K
bcgs5r62r35g0
1 May 20
Submission of Matters to a Vote of Security Holders
4:50pm
8-K
vxu8ia w2s17i3fu
6 Apr 20
Departure of Directors or Certain Officers
4:45pm
8-K
01pf26h7trp33xgcj7i
2 Mar 20
Departure of Directors or Certain Officers
4:50pm
8-K
hxrkcsb49dlglxj ya
13 Feb 20
Bio-Rad Reports Fourth-Quarter and Full-Year 2019 Financial Results
5:08pm
8-K
mfxozxqm8ieai2v
6 Dec 19
Regulation FD Disclosure
9:34pm
8-K
ar5u2gq 8dp34
25 Nov 19
Cost Associated with Exit or Disposal Activities
5:00pm
8-K
oche45jymosm4f
31 Oct 19
Bio-Rad Reports Third-Quarter 2019 Financial Results
4:49pm
8-K/A
fh8mrp4m6bo73l 470c
27 Aug 19
Bio-Rad Reports Second-Quarter 2019 Financial Results
5:16pm
8-K
kt5bss6w2yl6w
23 Aug 19
Departure of Directors or Certain Officers
5:01pm
8-K
ilr f9i7o2k9kkh
1 Aug 19
Bio-Rad Reports Second-Quarter 2019 Financial Results
4:47pm
8-K
e049xw zxs
8 May 19
Bio-Rad Reports First Quarter 2019 Financial Results
4:42pm
8-K
931vtthdlt95rkwqvf8
2 May 19
Submission of Matters to a Vote of Security Holders
5:05pm
8-K
x2q76eo3yxxb0kz
22 Apr 19
Bio-Rad Appoints Andrew Last as Executive Vice President and Chief Operating Officer
5:10pm
8-K
opgonjj4sl8p5h
16 Apr 19
Entry into a Material Definitive Agreement
5:00pm
8-K
vahqa3s9n6
2 Apr 19
Bio-Rad Names Ilan Daskal Executive Vice President and Chief Financial Officer
5:10pm
8-K
ht90st7o
25 Mar 19
Bio-Rad Laboratories, Inc. Receives Expected NYSE Notice Regarding Late Form10-K Filing
5:11pm
8-K
3ongtvp 20c8
18 Mar 19
Other Events
4:45pm
8-K
v4vyrl8pa gt8i5r4pqr
28 Feb 19
Bio-Rad Reports Fourth-Quarter and Full-Year 2018 Financial Results
4:46pm